全球领先的新经济产业第三方数据挖掘与分析机构
关于“医疗保障”的报告
艾媒咨询|2020上半年中国网络互助发展专题研究报告
本报告研究涉及企业/品牌/案例：e互助、相互宝。
在国家政策的支持下，中国网络互助行业不断发展，逐渐成为医疗保障的有益补充。2019年中国网络互助行业救助总人数规模超过3万人，行业救助总金额超50亿元。截至2019年年底，中国网络互助覆盖人数达1.5亿人，预计2020年中国网络互助覆盖率达17.8%，2022年网络互助覆盖人数达有望达到3.9亿，覆盖率将达27.8%。通过网络互助平台的对比，结果显示，相较于报销型和综合型平台，给付型和聚焦型平台在人均互助金、获助比例等方面更具优势，e互助综合能力领先各平台。目前没有发现网络互助行业的规模效应，平台会员分摊未来有望保持平稳发展。未来中国网络互助将进入繁荣发展期，有望成为“国民级”产品，专业化运营与风险管控将成平台重点发展方向，行业也将从同质化到募集效率、金额的差异化发展。
With the support of national policies, China's network mutual assistance industry has continued to develop and has gradually become a useful supplement to medical security. In 2019, the total number of people assisted by China's network mutual assistance industry exceeded 30,000, and the total amount of industry assistance exceeded 5 billion yuan. At the end of 2019, the number of people covered by China's network mutual assistance reached 150 million. It is estimated that the coverage rate of China's network mutual assistance will reach 17.8% in 2020, and the number of network mutual assistance coverage is expected to reach 390 million in 2022, with a coverage rate of 27.8%. Through the comparison of network mutual assistance platforms, the results show that, compared with reimbursement and integrated platforms, payment and focused platforms have more advantages in terms of per capita mutual assistance, the proportion of assistance and so on. Besides, the comprehensive ability of “E HUAZHU” leads all platforms. At present, the scale effect of the network mutual assistance industry has not been found, and the platform members are expected to maintain stable spending in the future. In the future, China's network mutual assistance will enter a period of prosperity and development, and it is expected to become a "national-level" product. Professional operation and risk management will become the key development direction of the platforms. The industry will also develop from homogeneity to differentiated development in raising efficiency and amount.-
艾媒咨询 | 2025年中国健康体检行业消费行为调查数据
随着人们健康意识的提升和疾病预防需求的增长，健康体检市场正飞速发展。消费者对健康管理的重视推动了体检市场的细分和升级，同时技术进步也带来了更精准的检测手段和更便捷的服务体验。根据全球新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国健康体检行业消费行为调查数据》数据显示，选择两年一次体检的消费者占比最高，达到39.41%，表明超过三分之一的消费者倾向于以两年为周期进行健康管理，反映出他们对定期体检的重视。与此同时，常规体检项目以60.62%的占比位居首位，凸显了大多数消费者对基础健康检查的高度关注。进一步分析发现，生化及实验室检测（包括血常规、尿常规、生化、肝功、肾功、甲功、血糖等）以61.89%的占比成为最受关注的健康指标，体现了消费者对全面、精准的健康数据的需求，也印证了基础检查在健康管理中的核心地位。艾媒咨询分析师认为，未来，随着健康大数据和人工智能的应用，健康体检市场将朝着更精准、更智能、更普惠的方向发展，成为大健康产业的重要组成部分。
With the improvement of people's health awareness and the growth of disease prevention demand, the health examination market is developing rapidly. Consumers' attention to health management has promoted the segmentation and upgrading of the physical examination market, while technological progress has also brought more accurate detection means and more convenient service experience. According to the latest "Survey data of consumption behavior of China's health check-up industry in 2025" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the proportion of consumers who choose a biennial physical examination is the highest, reaching 39.41%. It shows that more than one-third of consumers tend to conduct health management on a two-year cycle, reflecting the importance they attach to regular physical examinations. At the same time, routine physical examination items ranked first with 60.62%, highlighting the high attention of most consumers to basic health examination. Further analysis found that biochemical and laboratory tests (including blood routine, urine routine, biochemistry, liver function, kidney function, thyroid function, blood sugar, etc.) accounted for 61.89% of the most concerned health indicators, reflecting consumers' demand for comprehensive and accurate health data, and also confirmed the core position of basic examination in health management. Analysts believe that in the future, with the application of health big data and artificial intelligence, the health physical examination market will develop in a more accurate, smarter and more inclusive direction and become an important part of the big health industry. -
-
艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告
本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康
数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry. -
-
-
艾媒咨询|2021年中国轻医美行业研究及产业链分析报告
本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物
数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization. -
-
-
- 1
- 2
- 3
- 4
- 5
- 6
- 80
